• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • UNICEF support boosts safety, sanitation at Daudu camp
  • Rural connectivity key to inclusive digital growth, expert says
  • Ghana warns of El Niño-linked health risks as harmattan intensifies
  • Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence
  • IAR, NBMA train stakeholders on managing low-level presence of GM crops
  • PAN Kano plans accreditation for poultry input distributors
  • Health council backs new policies on telemedicine, E-pharmacy
  • Nigeria needs domestic funding for family planning, experts say
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    PAN Kano plans accreditation for poultry input distributors

    November 20, 2026

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    Rising feed costs push farmers out of business

    November 19, 2026
  • Sci & Tech

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    IAR, NBMA train stakeholders on managing low-level presence of GM crops

    November 20, 2026

    Sultan inaugurates 500-seat ICT centre at Saki nursing college, backs health technology expansion

    November 19, 2026

    Linking payment systems key to Africa’s trade integration, officials say

    November 19, 2026

    CJID announces 2026 media, development conference

    November 18, 2026
  • Health

    UNICEF support boosts safety, sanitation at Daudu camp

    November 20, 2026

    Health council backs new policies on telemedicine, E-pharmacy

    November 20, 2026

    Nigeria needs domestic funding for family planning, experts say

    November 20, 2026

    Foundation, ACF urge investment in boys’ development

    November 19, 2026

    Nigeria’s home care framework launched to support vulnerable people

    November 19, 2026
  • Environment

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026

    Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

    November 20, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026

    Nigeria targets open defecation free status by 2030

    November 19, 2026

    Erosion puts Cross River transmission line at risk

    November 19, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    UNICEF support boosts safety, sanitation at Daudu camp

    November 20, 2026

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    UNICEF support boosts safety, sanitation at Daudu camp

    November 20, 2026

    Rural connectivity key to inclusive digital growth, expert says

    November 20, 2026

    Ghana warns of El Niño-linked health risks as harmattan intensifies

    November 20, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»[EXPLAINER] Hepatitis: causes, symptoms, prevention
Health & Healthy Living

[EXPLAINER] Hepatitis: causes, symptoms, prevention

Abdallah el-KurebeBy Abdallah el-KurebeSeptember 1, 2024Updated:September 1, 2024No Comments4 Mins Read
Hepatitis
Share
Facebook Twitter LinkedIn Pinterest Email

What is hepatitis?

According to the WHO, hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and non-infectious agents leading to a range of health problems, some of which can be fatal.

The virus has five main strains referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of the illness, geographical distribution and prevention methods.

In particular, types B and C lead to chronic disease in hundreds of millions of people and together are the most common cause of liver cirrhosis, liver cancer and viral hepatitis-related deaths. An estimated 354 million people worldwide live with B or C, and for most, testing and treatment remain beyond reach.

What are its symptoms?

The most common symptoms include:

  • Dark urine.
  • Stomach pain.
  • Yellow skin or eye whites, called jaundice.
  • Pale or clay-colored stool.
  • Low-grade fever.
  • Loss of appetite.
  • Fatigue.
  • Feeling sick to your stomach.
  • Aching joints.

Contact your healthcare provider as soon as possible if you have any or a combination of these symptoms.

What are its causes?

It is caused by a virus and can either be acute (lasting less than six months) or chronic (lasting more than six months). It can be spread from person to person. Some of its types can be spread through sexual contact.

How do we prevent it?

  1. Get vaccinated for Hepatitis A and B.
  2. Use clean and safe drinking water.
  3. Practice good hand hygiene, especially before eating.
  4. Avoid sharing needles or other drug paraphernalia.
  5. Use barrier protection (like condoms) during sexual activity
  6. Ensure safe blood transfusions and medical procedures
  7. Avoid sharing personal items like razors or toothbrushes
  8. Repost

How do we manage and treat it?

ALSO READ [EXPLAINER] What causes foamy urine?

There are no treatments to cure hepatitis A, aside from carefully monitoring liver function. If you know you have hepatitis A early enough, you might be able to stop the infection if you get a dose of the hepatitis A vaccine or something called hepatitis A immune globulin.

Hepatitis B, when chronic, can often be treated successfully. The most commonly used drugs to treat chronic hepatitis B are:

  • Entecavir (Baraclude®).
  • Telbivudine (Tyzeka®).
  • Tenofovir alafenamide (Vemlidy®).
  • Tenofovir disoproxil fumarate (Viread®).
  • Interferon alfa-2b (Intron A®).
  • Peginterferon alfa-2a (Pegasys®).

For hepatitis C, the following drugs are used:

  • Simeprevir (Olysio®).
  • Daclatasvir (Daklinza®).
  • Sofosbuvir (Solvadi®); sofusbuvir/velpatasvir (Epclusa®); sofusbuvir/velpatasvir/voxilaprevir (Vosevi®); ledipasvir/sofosbuvir (Harvoni®).
  • Ombitasvir/paritaprevir/ritonavir (Technivie®); ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira® Pak, Viekira® XR).
  • Elbasivir/grazoprevir (Zepatier®).
  • Glecaprevir/pibrentasvir (Mavyret®).

These new drugs are sometimes given with older drugs like ribavirin and peginterferon alfa-2a and peginterferon-2b. You might have to take these medicines for some time, even as long as six months.

If you have chronic hepatitis D, your doctor may prescribe drugs with interferons and might also add medicines for B. Hepatitis E treatments include peginterferon alfa-2a and ribavirin.

Is there a vaccine for it?

There are vaccines for hepatitis A and B that are available in the U.S. There is no vaccine for hepatitis C. Since you can only get hepatitis D if you have B, getting the vaccine against B should protect you against D. There is no FDA approved vaccine against hepatitis E, but vaccines against E exist overseas (for example, in China).

What is the outlook for hepatitis?

Hepatitis A and E usually only cause short-term (acute) infections that your body can overcome. The others (B, C and D) can also cause acute infections, but might also cause chronic (long-term) infections. The chronic forms are more dangerous. Hepatitis non-E is usually acute, but can become chronic.

Most people recover fully from the virus even though it might take several months for the liver to heal. To help improve your health and to help speed up your recovery:

  • Avoid alcohol.
  • Practice good nutrition.
  • If you feel sick, rest.
  • Talk to your healthcare provider about your medicines, even over-the-counter drugs or vitamins and supplements, to know which ones you should take and which to avoid until you are recovered.

With hepatitis, your healthcare provider will also be looking for long-term damage to the liver in the forms of cirrhosis or liver failure. You may be asked to take other types of tests, such as liver function tests, imaging tests or possibly a liver biopsy.

Viral hepatitis WHO
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

UNICEF support boosts safety, sanitation at Daudu camp

November 20, 2026

Health council backs new policies on telemedicine, E-pharmacy

November 20, 2026

Nigeria needs domestic funding for family planning, experts say

November 20, 2026

Leave A Reply Cancel Reply

UNICEF support boosts safety, sanitation at Daudu camp

November 20, 2026

Rural connectivity key to inclusive digital growth, expert says

November 20, 2026

Ghana warns of El Niño-linked health risks as harmattan intensifies

November 20, 2026

Ghana’s UCC Vice-Chancellor meets 12-year-old student, urges focus on excellence

November 20, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.